Covered recipient · General Payments record
VICTORIA CATHERINE KURITZA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,449.22
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $752.53 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $320.51 | 11 |
| Lilly USA, LLC | $155.39 | 9 |
| GENZYME CORPORATION | $74.95 | 2 |
| LEO Pharma Inc. | $45.06 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.59 | 1 |
| UCB, Inc. | $36.94 | 1 |
| Incyte Corporation | $27.99 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.68 | 1 |
| Janssen Biotech, Inc. | $23.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.91 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120310 | CMS |
| ABBVIE INC. | $157.26 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120312 | CMS |
| ABBVIE INC. | $8.37 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120314 | CMS |
| ABBVIE INC. | $25.05 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120316 | CMS |
| ABBVIE INC. | $7.78 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120318 | CMS |
| ABBVIE INC. | $4.01 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120320 | CMS |
| ABBVIE INC. | $2.05 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120322 | CMS |
| ABBVIE INC. | $17.32 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120324 | CMS |
| ABBVIE INC. | $19.46 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120326 | CMS |
| ABBVIE INC. | $33.07 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120328 | CMS |
| ABBVIE INC. | $23.23 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104120330 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117901154 | CMS |
| GENZYME CORPORATION | $35.87 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139751125 | CMS |
| GENZYME CORPORATION | $39.08 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139751153 | CMS |
| Incyte Corporation | $27.99 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141264995 | CMS |
| Janssen Biotech, Inc. | $23.42 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078601601 | CMS |
| LEO Pharma Inc. | $24.05 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152638915 | CMS |
| LEO Pharma Inc. | $21.01 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152638917 | CMS |
| Lilly USA, LLC | $27.50 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135440341 | CMS |
| Lilly USA, LLC | $29.11 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472459 | CMS |
| Lilly USA, LLC | $5.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135475626 | CMS |
| Lilly USA, LLC | $4.77 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135452033 | CMS |
| Lilly USA, LLC | $26.20 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496492 | CMS |
| Lilly USA, LLC | $24.91 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496494 | CMS |
| Lilly USA, LLC | $1.76 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472457 | CMS |
| Lilly USA, LLC | $27.68 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135490402 | CMS |
| Lilly USA, LLC | $7.82 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135507378 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.68 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152210646 | CMS |
| UCB, Inc. | $36.94 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143186323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.